Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/153802
Full metadata record
DC FieldValueLanguage
dc.creatorTaheri, Y
dc.creatorSharifi-Rad, J
dc.creatorAntika, G
dc.creatorYilmaz, YB
dc.creatorTumer, TB
dc.creatorAbuhamdah, S
dc.creatorChandra, S
dc.creatorSaklani, S
dc.creatorKiliç, CS
dc.creatorSestito, S
dc.creatorDastan, SD
dc.creatorKumar, M
dc.creatorAlshehri, MM
dc.creatorRapposelli, S
dc.creatorMartins, N
dc.creatorCho, WC
dc.date.accessioned2023-11-08T09:57:50Z-
dc.date.available2023-11-08T09:57:50Z-
dc.date.issued2021
dc.identifier.issn1942-0900
dc.identifier.urihttps://hdl.handle.net/10216/153802-
dc.description.abstractLuteolin is a naturally occurring secondary metabolite belonging to the class of flavones. As many other natural flavonoids, it is often found in combination with glycosides in many fruits, vegetables, and plants, contributing to their biological and pharmacological value. Many preclinical studies report that luteolin present excellent antioxidant, anticancer, antimicrobial, neuroprotective, cardioprotective, antiviral, and anti-inflammatory effects, and as a consequence, various clinical trials have been designed to investigate the therapeutic potential of luteolin in humans. However, luteolin has a very limited bioavailability, which consequently affects its biological properties and efficacy. Several drug delivery strategies have been developed to raise its bioavailability, with nanoformulations and lipid carriers, such as liposomes, being the most intensively explored. Pharmacological potential of luteolin in various disorders has also been underlined, but to some of them, the exact mechanism is still poorly understood. Given the great potential of this natural antioxidant in health, this review is aimed at providing an extensive overview on the in vivo pharmacological action of luteolin and at stressing the main features related to its bioavailability, absorption, and metabolism, while essential steps determine its absolute health benefits and safety profiles. In addition, despite the scarcity of studies on luteolin bioavailability, the different drug delivery formulations developed to increase its bioavailability are also listed here.
dc.description.sponsorshipThis study was partially supported by Çanakkale Onsekiz Mart Üniversitesi (Scientific Research Projects, ID: FYL-2017-1339 and FBA-2017-1268).
dc.language.isoeng
dc.publisherHindawi
dc.relation.ispartofOxidative Medicine and Cellular Longevity, vol.2021:1987588
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subject.meshAnimals
dc.subject.meshAnti-Inflammatory Agents / chemistry
dc.subject.meshAnti-Inflammatory Agents / pharmacokinetics
dc.subject.meshAnti-Inflammatory Agents / pharmacology
dc.subject.meshAnti-Inflammatory Agents / therapeutic use
dc.subject.meshAntineoplastic Agents / chemistry
dc.subject.meshAntineoplastic Agents / pharmacokinetics
dc.subject.meshAntineoplastic Agents / pharmacology
dc.subject.meshApoptosis / drug effects
dc.subject.meshBiological Availability
dc.subject.meshDrug Carriers / chemistry
dc.subject.meshHumans
dc.subject.meshLuteolin / chemistry
dc.subject.meshLuteolin / pharmacokinetics
dc.subject.meshLuteolin / pharmacology
dc.subject.meshLuteolin / therapeutic use
dc.subject.meshPhagocytosis / drug effects
dc.subject.meshSepsis / drug therapy
dc.titlePaving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on in Vivo Pharmacological Effects and Bioavailability Traits
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1155/2021/1987588
dc.relation.publisherversionhttps://www.hindawi.com/journals/omcl/2021/1987588/
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1155-2021-1987588.pdf1.32 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons